https://www.selleckchem.com/pr....oducts/l-nmma-acetat
Future phase II/III studies in this disease should focus on sequencing of surgery and immunotherapy with a design of curative intent. This case report of a patient with perivascular epithelioid cell tumor treated successfully with programmed cell death protein-1 targeted therapy suggests that programmed cell death ligand-1 levels should be measured in patients with perivascular epithelioid cell tumor and immunotherapy considered for recurrent or metastatic patients. Future phase II/III studies in this disease should focus on sequ
Curtir
Comentario
Compartilhar
